IP Library › Granted Patent US 11,186,592
Granted Patent B2
US 11,186,592 · App. 16/635,356 · Granted Nov 30, 2021

Thiazolopyridine derivatives as adenosine receptor antagonists

Inventors: Eva-Maria Tanzer (Darmstadt, DE); Kai Schiemann (Seeheim-Jugenheim, DE); Markus Klein (Darmstadt, DE)
Assignee: Merck Patent GmbH
C07D513/04C07D519/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,186,592
App. No.
16/635,356
Granted
Nov 30, 2021
Kind
B2
Abstract

The invention relates to thiazolopyridine derivatives of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.

Claims (840)

1. A compound of formula I,

wherein

R 1 is linear or branched alkyl having 1-10 C atoms which is unsubstituted or mono-, di- or trisubstituted by R 5 and in which 1-4 C atoms may be replaced, independently of one another, by O, S, SO, SO 2 , NH, NCH 3 , —OCO, —NHCONH—, —NHCO—, —NR 6 SO 2 R 7 —, —COO—, —CONH—, —NCH 3 CO—, —CONCH 3 —, —C≡C— groups and/or —CH═CH— groups, and/or, in addition, 1-10 H atoms may be replaced by F and/or Cl, or mono- or bicyclic cyclic alkyl having 3-7 C atoms which is unsubstituted or mono-, di- or trisubstituted by R 5 and in which 1-4 C atoms may be replaced, independently of one another, by O, S, SO, SO 2 , NH, NCH 3 , —OCO—, —NHCONH—, —NHCO—, —NR 6 SO 2 R 7 —, —COO—, —CONH—, —NCH 3 CO—, —CONCH 3 —, —C≡C— groups and/or by —CH═CH— groups and/or, in addition, 1-10 H atoms may be replaced by F and/or Cl, or mono- or bicyclic heteroaryl, heterocyclyl, aryl or cyclic alkylaryl, containing 3 to 14 carbon atoms and 0-4 heteroatoms, independently selected from N, O and S, which is unsubstituted or mono-, di- or trisubstituted by R 5 ,

R 2 is linear or branched alkyl having 1-10 C atoms which is unsubstituted or mono-, di- or trisubstituted by R 5 and in which 1-4 C atoms may be replaced, independently of one another, by O, S, SO, SO 2 , NH, NCH 3 , —OCO—, —NHCONH—, —NHCO—, —NR 6 SO 2 R 7 —, —COO—, —CONH—, —NCH 3 CO—, —CONCH 3 —, —C≡C— groups and/or —CH═CH— groups, and/or, in addition, 1-10 H atoms may be replaced by F and/or Cl, or cyclic alkyl having 3-7 C atoms which is unsubstituted or mono-, di- or trisubstituted by R 5 and in which 1-4 C atoms may be replaced, independently of one another, by O, S, SO, SO 2 , NH, NCH 3 , —OCO—, —NHCONH—, —NHCO—, —NR 6 SO 2 R 7 —, —COO—, —CONH—, —NCH 3 CO—, —CONCH 3 —, —C≡C— groups and/or by —CH═CH— groups and/or, in addition, 1-11 H atoms may be replaced by F and/or Cl, or mono- or bicyclic heteroaryl, heterocyclyl, aryl or cyclic alkylaryl, containing 3 to 14 carbon atoms and 0-4 heteroatoms, independently selected from N, O and S, which is unsubstituted or mono-, di- or trisubstituted by R 5 ,

R 3 is linear or branched alkyl or O-alkyl having 1-6 C atoms or cyclic alkyl having 3-6 C atoms, which is unsubstituted or mono-, di- or trisubstituted by H, ═S, ═NH, ═O, OH, cyclic alkyl having 3-6 C atoms, COOH, Hal, NH 2 , SO 2 CH 3 , SO 2 NH 2 , CN, CONH 2 , NHCOCH 3 , NHCONH 2 or NO 2 ,

R 4 is H, D, linear or branched alkyl having 1-6 C atoms or Hal,

R 5 is H, R 6 , ═S, ═NR 6 , ═O, OH, COOH, Hal, NH 2 , SO 2 CH 3 , SO 2 NH 2 , CN, CONH 2 , NHCOCH 3 , NHCONH 2 , NO 2 , or linear or branched alkyl having 1-10 C atoms which is unsubstituted or mono-, di- or trisubstituted by R 6 and in which 1-4 C atoms may be replaced, independently of one another, by O, S, SO, SO 2 , NH, NCH 3 , —OCO—, —NHCONH—, —NHCO—, —NR 6 SO 2 R 7 —, —COO—, —CONH—, —NCH 3 CO—, —CONCH 3 —, —C≡C— groups and/or —CH═CH— groups, and/or, in addition, 1-10 H atoms may be replaced by F and/or CI, or mono- or bicyclic cyclic alkyl having 3-7 C atoms which is unsubstituted or mono-, di- or trisubstituted by by R 6 and in which 1-4 C atoms may be replaced, independently of one another, by O, S, SO, SO 2 , NH, NCH 3 , —OCO—, —NHCONH—, —NHCO—, —NR 6 SO 2 R 7 —, —COO—, —CONH—, —NCH 3 CO—, —CONCH 3 —, —C≡C— groups and/or by —CH═CH— groups and/or, in addition, 1-10 H atoms may be replaced by F and/or CI, or mono- or bicyclic heteroaryl, heterocyclyl, aryl or cyclic alkylaryl, containing 3 to 14 carbon atoms and 0-4 heteroatoms, independently selected from N, O and S, which is unsubstituted or mono-, di- or trisubstituted by R 6 ,

R 6 , R 7 are independently of one another selected from the group consisting of H, ═S, ═NH, ═O, OH, COOH, Hal, NH 2 , SO 2 CH 3 , SO 2 NH 2 , CN, CONH 2 , NHCOCH 3 , NHCONH 2 , NO 2 and linear or branched alkyl having 1-10 C atoms in which 1-4 C atoms may be replaced, independently of one another, by O, S, SO, SO 2 , NH, NCH 3 , —OCO—, —NHCONH—, —NHCO—, —COO—, —CONH—, —NCH 3 CO—, —CONCH 3 —, —C≡C— groups and/or —CH═CH— groups, and/or, in addition, 1-10 H atoms may be replaced by F and/or Cl,

Hal is F, Cl, Br, or I,

D is deuterium

or physiologically acceptable salts, solvates, prodrugs or stereoisomers thereof, including mixtures thereof in all ratios.

2. The compound according to claim 1 , wherein R 1 is linear or branched alkyl having 1-10 C atoms which is unsubstituted or mono-, di- or trisubstituted by R 4 and in which 1-4 C atoms may be replaced, independently of one another, by O, S, SO, SO 2 , NH, NCH 3 , —OCO—, —NHCONH—, —NHCO—, —NR 5 SO 2 R 6 —, —COO—, —CONH—, —NCH 3 CO—, —CONCH 3 —, —C≡C— groups and/or —CH═CH— groups, and/or, in addition, 1-10 H atoms may be replaced by F and/or Cl, or one of the following structures:

which is unsubstituted or mono-, di- or trisubstituted with R 5

and wherein R 2 , R 3 , R 4 , R 5 , R 6 and R 7 have the meanings as disclosed in claim 1 , or physiologically acceptable salts, solvates, prodrugs or stereoisomers thereof, including mixtures thereof in all ratios.

3. The compound according to claim 1 , wherein

R 1 is one of the following structures:

and wherein R 2 , R 3 , R 4 , R 5 , R 6 and R 7 have the meanings as disclosed in claim 1 , or physiologically acceptable salts, solvates, prodrugs or stereoisomers thereof, including mixtures thereof in all ratios.

4. The compound according to claim 1 , wherein

R 1 is phenyl, methylpyrazole or dihydropyran

and R 2 , R 3 , R 4 , R 5 , R 6 and R 7 have the meanings as in claim 1 , or physiologically acceptable salts, solvates, prodrugs or stereoisomers thereof, including mixtures thereof in all ratios.

5. The compound according to claim 1 , wherein

R 2 is one of the following structures:

which is unsubstituted or mono-, di- or trisubstituted with R 5

and wherein R 1 , R 3 , R 4 , R 5 , R 6 and R 7 have the meanings as disclosed in claim 1 , and physiologically acceptable salts, derivatives, solvates, prodrugs and stereoisomers thereof, including mixtures thereof in all ratios.

6. The compound according to claim 1 , wherein

R 2 is one of the following structures:

and wherein R 1 , R 3 , R 4 , R 5 , R 6 and R 7 have the meanings as disclosed in claim 1 , or physiologically acceptable salts, solvates, prodrugs or stereoisomers thereof, including mixtures thereof in all ratios.

7. The compound according to claim 1 , wherein

R 3 one of the following structures

and R 1 , R 2 , R 4 , R 5 , R 6 and R 7 have the meanings as disclosed in claim 1 , or physiologically acceptable salts, solvates, prodrugs or stereoisomers thereof, including mixtures thereof in all ratios.

8. The compound according to claim 1 , wherein

R 3 is OMe

and R 1 , R 2 , R 4 , R 5 , R 6 and R 7 have the meanings as disclosed in claim 1 , or physiologically acceptable salts, solvates, prodrugs or stereoisomers thereof, including mixtures thereof in all ratios.

9. The compound according to claim 1 , wherein

R 1 is phenyl, methylpyrazole or dihydropyran,

R 3 is OMe

and R 2 , R 4 , R 5 , R 6 and R 7 have the meanings as disclosed in claim 1 , or physiologically acceptable salts, solvates, prodrugs or stereoisomers thereof, including mixtures thereof in all ratios.

10. The compound according to claim 1 , wherein

R 4 is H, D, methyl, ethyl, F, Br or Cl

and wherein R 1 , R 2 , R 3 , R 5 , R 6 and R 7 have the meanings as disclosed in claim 1 , or physiologically acceptable salts, solvates, prodrugs or stereoisomers thereof, including mixtures thereof in all ratios.

11. The compound according to claim 1 , wherein

R 4 is H,

and wherein R 1 , R 2 , R 3 , R 5 , R 6 and R 7 have the meanings as disclosed in claim 1 , or physiologically acceptable salts, solvates, prodrugs or stereoisomers thereof, including mixtures thereof in all ratios.

12. A compound selected from the group consisting of:

 1

4-Hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-

morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

 2

4-Dimethylaminomethyl-N-(4-methoxy-7-morpholin-4-yl-

thiazolo[4,5-c]pyridin-2-yl)-benzamide

 3

4-Methoxymethyl-N-(4-methoxy-7-morpholin-4-yl-thiazolo[4,5-

c]pyridin-2-yl)-benzamide

 4

1-(2-Methoxy-ethyl)-1H-pyrazole-4-carboxylic acid (4-methoxy-7-

morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

 5

2-Dimethylaminomethyl-N-(4-methoxy-7-morpholin-4-yl-

thiazolo[4,5-c]pyridin-2-yl)-isonicotinamide

 6

2-Methoxymethyl-N-(4-methoxy-7-morpholin-4-yl-thiazolo[4,5-

c]pyridin-2-yl)-isonicotinamide

 7

4-benzyl-4-hydroxy-N-[4-methoxy-7-(morpholin-4-yl)-

[1,3]thiazolo[4,5-c]pyridin-2-yl]piperidine-1-carboxamide

 8

N-[4-methoxy-7-(morpholin-4-yl)-[1,3]thiazolo[4,5-c]

pyridin-2-yl]-5-(2-methoxyethoxy)pyrazine-2-carboxamide

 9

2-Oxa-7-aza-spiro[4.4]nonane-7-carboxylic acid (4-methoxy-7-

morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

 10

3-Hydroxy-3-methyl-pyrrolidine-1-carboxylic acid (4-methoxy-7-

morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

 11

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (4-methoxy-7-

morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

 12

4-Hydroxy-4-prop-2-ynyl-piperidine-1-carboxylic acid (4-methoxy-

7-morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

 13

1-(2-Methoxy-ethyl)-1H-pyrazole-4-carboxylic acid [4-methoxy-7-

(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 14

4-Methoxymethyl-N-[4-methoxy-7-(1-methyl-1H-pyrazol-4-yl)-

thiazolo[4,5-c]pyridin-2-yl]-benzamide

 15

N-(4-Methoxy-7-morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-

N′,N′-dimethyl-terephthalamide

 16

4-Hydroxymethyl-4-methyl-piperidine-1-carboxylic acid (4-

methoxy-7-morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

 17

(5S)-N-[4-methoxy-7-(morpholin-4-yl)-[1,3]thiazolo[4,5-c]pyridin-

2-yl]-2-oxa-7-azaspiro[4.4]nonane-7-carboxamide

 18

(5R)-N-[4-methoxy-7-(morpholin-4-yl)-[1,3]thiazolo[4,5-c]pyridin-

2-yl]-2-oxa-7-azaspiro[4.4]nonane-7-carboxamide

 19

N-[4-Methoxy-7-(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-

2-yl]-benzamide

 20

4-Methoxy-7-(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-

2-ylamine

 21

4-Hydroxy-4-methyl-piperidine-1-carboxylic acid [4-methoxy-7-(1-

methyl-1H-pyrazol-4-y1)-thiazolo[4,5-c]pyridin-2-yl]-amide

 22

4-Dimethylaminomethyl-N-[4-methoxy-7-(1-methyl-1H-pyrazol-4-

yl)-thiazolo[4,5-c]pyridin-2-yl]-benzamide

 23

4-Methoxymethyl-N-[4-methoxy-7-(tetrahydro-pyran-4-yl)-

thiazolo[4,5-c]pyridin-2-yl]-benzamide

 24

2-Dimethylaminomethyl-N-[4-methoxy-7-(1-methyl-1H-pyrazol-4-

yl)-thiazolo[4,5-c]pyridin-2-yl]-isonicotinamide

 25

2-Dimethylaminomethyl-N-[4-methoxy-7-(tetrahydro-pyran-4-yl)-

thiazolo[4,5-c]pyridin-2-yl]-isonicotinamide

 26

2-Methoxymethyl-N-[4-methoxy-7-(1-methyl-1H-pyrazol-4-yl)-

thiazolo[4,5-c]pyridin-2-yl]-isonicotinamide

 27

4-Dimethylaminomethyl-N-[4-methoxy-7-(tetrahydro-pyran-4-yl)-

thiazolo[4,5-c]pyridin-2-yl]-benzamide

 28

2-Methoxymethyl-N-[4-methoxy-7-(tetrahydro-pyran-4-yl)-

thiazolo[4,5-c]pyridin-2-yl]-isonicotinamide

 29

1-(2-Methoxy-ethyl)-1H-pyrazole-4-carboxylic acid [4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 30

4-Hydroxy-4-methyl-piperidine-1-carboxylic acid [4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 31

Isoxazole-4-carboxylic acid (4-methoxy-7-morpholin-4-yl-

thiazolo[4,5-c]pyridin-2-yl)-amide

 32

4-Hydroxy-4-methyl-piperidine-1-carboxylic acid (4-

fluoromethoxy-7-morpholin-4-yl-thiazolo[4,5-c]pyridin-

2-yl)-amide

 33

4-Imidazol-1-ylmethyl-N-(4-methoxy-7-morpholin-4-yl-

thiazolo[4,5-c]pyridin-2-yl)-benzamide

 34

7-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (4-methoxy-7-

morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

 35

1-(2-Methoxy-ethyl)-1H-pyrazole-4-carboxylicacid (4-methoxy-7-

pyridin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

 36

1-(2-Methoxy-ethyl)-1H-pyrazole-4-carboxylicacid [4-methoxy-7-

(6-methyl-pyridazin-3-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 37

4-Hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-

phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

 38

4-Difluoromethyl-4-hydroxy-piperidine-1-carboxylic acid (4-

methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

 39

4-Hydroxymethyl-4-methyl-piperidine-1-carboxylic acid (4-

methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

 40

4-Fluoromethyl-4-hydroxy-piperidine-1-carboxylic acid (4-

methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

 41

3-Oxa-9-aza-spiro[5.5]undecane-9-carboxylic acid (4-methoxy-7-

phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

 42

4-Methyl-piperidine-1-carboxylic acid (4-methoxy-7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-amide

 43

4-Benzyl-4-hydroxy-piperidine-1-carboxylic acid (4-methoxy-7-

phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

 44

2-Oxo-1-oxa-3,8-diaza-spiro[4.5]decane-8-carboxylic acid (4-

methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

 45

3-Oxo-2,8-diaza-spiro[4.5]decane-8-carboxylic acid (4-

methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

 46

4-Dimethylaminomethyl-N-(4-methoxy-7-phenyl-thiazolo[4,5-

c]pyridin-2-yl)-benzamide

 47

4-Methoxymethyl-N-(4-methoxy-7-phenyl-thiazolo[4,5-

c]pyridin-2-yl)-benzamide

 48

2,4-Dioxo-1,3,8-triaza-spiro[4.5]decane-8-carboxylic acid (4-

methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

 49

4′-Hydroxy-3′,4′,5′,6′-tetrahydro-2′H-[3,4′]bipyridinyl-1′-

carboxylic acid (4-methoxy-7-phenyl-thiazolo[4,5-c]pyridin-

2-yl)-amide

 50

4-Oxo-piperidine-1-carboxylic acid (4-methoxy-7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-amide

 51

1-Oxo-2,8-diaza-spiro[4.5]decane-8-carboxylic acid (4-

methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

 52

7-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (4-

methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

 53

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (4-

methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

 54

2-Oxa-7-aza-spiro[4.5]nonane-7-carboxylic acid (4-

methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

 55

4-Imidazol-1-ylmethyl-N-(4-methoxy-7-phenyl-thiazolo[4,5-

c]pyridin-2-yl)-benzamide

 56

Isoxazole-3-carboxylic acid (4-methoxy-7-phenyl-thiazolo[4,5-

c]pyridin-2-yl)-amide

 57

4-Hydroxy-4-prop-2-ynyl-piperidine-1-carboxylic acid(4-methoxy-

7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

 58

N-(4-Methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-N′,N′-

dimethyl-terephthalamide

 59

N-(4-Methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-4-

trifluoromethoxy-benzamide

 60

2-Methyl-oxazole-4-carboxylic acid (4-methoxy-7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-amide

 61

Benzooxazole-5-carboxylic acid (4-methoxy-7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-amide

 62

N-(4-Methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-4-(2-oxo-

pyrrolidin-1-ylmethyl)-benzamide

 63

2,3-Dihydro-benzofuran-5-carboxylic acid (4-methoxy-7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-amide

 64

3-Methoxymethyl-pyrrolidine-1-carboxylic acid (4-methoxy-7-

phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

 65

Piperidine-1,4-dicarboxylic acid 4-amide 1-[(4-methoxy-7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-amide]

 66

4-Diethylamino-N-(4-methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-

yl)-benzamide

 67

4-Difluoromethyl-4-hydroxy-piperidine-1-carboxylic acid [4-

methoxy-7-(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-

2-yl]-amide

 68

4-Hydroxymethy1-4-methyl-piperidine-l-carboxylic acid [4-

methoxy-7-(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-

2-yl]-amide

 69

4-Fluoromethyl-4-hydroxy-piperidine-1-carboxylic acid [4-

methoxy-7-(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-

2-yl]-amide

 70

3-Oxa-9-aza-spiro[5.5]undecane-9-carboxylic acid [4-

methoxy-7-(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-

2-yl]-amide

 71

4-Methyl-piperidine-1-carboxylic acid [4-methoxy-7-(1-methyl-

1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 72

4-Benzyl-4-hydroxy-piperidine-1-carboxylic acid [4-methoxy-

7-(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-

yl]-amide

 73

2-Oxo-l-oxa-3,8-diaza-spiro[4.5]decane-8-carboxylic acid [4-

methoxy-7-(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-

2-yl]-amide

 74

3-Oxo-2,8-diaza-spiro[4.5]decane-8-carboxylic acid [4-methoxy-7-

(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 75

4-Dimethylaminomethyl-N-[4-methoxy-7-(1-methyl-1H-

pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-benzamide

 76

2,4-Dioxo-1,3,8-triaza-spiro[4.5]decane-8-carboxylic acid [4-

methoxy-7-(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-

2-yl]-amide

 77

4′-Hydroxy-3′,4′,5′,6′-tetrahydro-2′H-[3,4′]bipyridinyl-1′-

carboxylic acid [4-methoxy-7-(1-methyl-1H-pyrazol-4-

yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 78

4-Oxo-piperidine-1-carboxylic acid [4-methoxy-7-(1-methyl-

1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 79

1-Oxo-2,8-diaza-spiro[4.5]decane-8-carboxylic acid [4-methoxy-7-

(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 80

7-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [4-methoxy-7-(1-

methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 81

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [4-methoxy-7-(1-

methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 82

2-Oxa-7-aza-spiro[4.4]nonane-7-carboxylic acid [4-methoxy-7-(1-

methyl-1H-pyrazol-4-yl)-thiazolo [4,5-c]pyridin-2-yl]-amide

 83

4-Imidazol-1-ylmethyl-N-[4-methoxy-7-(1-methyl-1H-pyrazol-4-

yl)-thiazolo[4,5-c]pyridin-2-yl]-benzamide

 84

Isoxazole-3-carboxylic acid [4-methoxy-7-(1-methyl-1H-pyrazol-4-

yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 85

4-Hydroxy-4-prop-2-ynyl-piperidine-l-carboxylic acid [4-methoxy-

7-(1-methyl-1H-pyrazol-4-yl)-thiazolo [4,5-c]pyridin-2-yl]-amide

 86

N-[4-Methoxy-7-(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-

2-yl]-N′,N′-dimethyl-terephthalamide

 87

N-[4-Methoxy-7-(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-

2-yl]-4-trifluoromethoxy-benzamide

 88

2-Methyl-oxazole-4-carboxylic acid [4-methoxy-7-(1-methyl-1H-

pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 89

Benzooxazole-5-carboxylic acid [4-methoxy-7-(1-methyl-1H-

pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 90

N-[4-Methoxy-7-(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-

c]pyridin-2-yl]-4-(2-oxo-pyrrolidin-1-ylmethyl)-benzamide

 91

2,3-Dihydro-benzofuran-5-carboxylic acid [4-methoxy-7-(1-

methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 92

3-Methoxymethyl-pyrrolidine-1-carboxylic acid [4-methoxy-7-(1-

methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 93

Piperidine-1,4-dicarboxylic acid 4-amide 1-{[4-methoxy-7-(1-

methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide}

 94

4-Diethylamino-N-[4-methoxy-7-(1-methyl-1H-pyrazol-4-yl)-

thiazolo[4,5-c]pyridin-2-yl]-benzamide

 95

4-Difluoromethyl-4-hydroxy-piperidine-1-carboxylic acid [4-

methoxy-7-(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-

amide

 96

4-Hydroxymethyl-4-methyl-piperidine-1-carboxylic acid [4-

methoxy-7-(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-

amide

 97

4-Fluoromethyl-4-hydroxy-piperidine-l-carboxylic acid [4-

methoxy-7-(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-

amide

 98

3-Oxa-9-aza-spiro[5.5]undecane-9-carboxylic acid [4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

 99

4-Methyl-piperidine-1-carboxylic acid [4-methoxy-7-(tetrahydro-

pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

100

4-Benzyl-4-hydroxy-piperidine-1-carboxylic acid [4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

101

2-Oxo-1-oxa-3,8-diaza-spiro[4.5]decane-8-carboxylic acid [4-

methoxy-7-(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-

amide

102

3-Oxo-2,8-diaza-spiro[4.5]decane-8-carboxylic acid [4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

103

2,4-Dioxo-1,3,8-triaza-spiro[4.5]decane-8-carboxylic acid [4-

methoxy-7-(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-

2-yl]-amide

104

4′-Hydroxy-3′,4′,5′,6′-tetrahydro-2′H-[3,4′]bipyridinyl-1′-

carboxylic acid [4-methoxy-7-(tetrahydro-pyran-4-yl)-

thiazolo[4,5-c]pyridin-2-yl]-amide

105

4-Oxo-piperidine-1-carboxylic acid [4-methoxy-7-(tetrahydro-

pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

106

1-Oxo-2,8-diaza-spiro[4.5]decane-8-carboxylic acid [4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

107

7-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

108

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

109

2-Oxa-7-aza-spiro[4.4]nonane-7-carboxylic acid [4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

110

4-Imidazol-1-ylmethyl-N-[4-methoxy-7-(tetrahydro-pyran-4-yl)-

thiazolo[4,5-c]pyridin-2-yl]-benzamide

111

Isoxazole-3-carboxylic acid [4-methoxy-7-(tetrahydro-pyran-4-yl)-

thiazolo[4,5-c]pyridin-2-yl]-amide

112

4-Hydroxy-4-prop-2-ynyl-piperidine-1-carboxylic acid [4-methoxy-

7-(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

113

N-[4-Methoxy-7-(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-

yl]-N′,N′-dimethyl-terephthalamide

114

N-[4-Methoxy-7-(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-

yl]-4-trifluoromethoxy-benzamide

115

2-Methyl-oxazole-4-carboxylic acid [4-methoxy-7-(tetrahydro-

pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

116

Benzooxazole-5-carboxylic acid [4-methoxy-7-(tetrahydro-pyran-4-

yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

117

N-[4-Methoxy-7-(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-

yl]-4-(2-oxo-pyrrolidin-l-ylmethyl)-benzamide

118

2,3-Dihydro-benzofuran-5-carboxylic acid [4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

119

3-Methoxymethyl-pyrrolidine-1-carboxylic acid [4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

120

Piperidine-1,4-dicarboxylic acid 4-amide 1-{[4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo [4,5-c]pyridin-2-yl]-amide}

121

4-Diethylamino-N-[4-methoxy-7-(tetrahydro-pyran-4-yl)-

thiazolo[4,5-c]pyridin-2-yl]-benzamide

122

{1-[4-Methoxy-7-(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-

c]pyridin-2-ylcarbamoyl]-piperidin-3-yl}-acetic acid

123

Pyridine-2,5-dicarboxylic acid 2-dimethylamide 5-{[4-methoxy-7-

(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-

yl]-amide}

124

1-Methyl-1H-pyrazole-4-carboxylic acid [4-methoxy-7-(1-methyl-

1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

125

5-Methyl-isoxazole-4-carboxylic acid [4-methoxy-7-(1-methyl-1H-

pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

126

1-(2-Methoxy-ethyl)-1H-[1,2,3]triazole-4-carboxylic acid [4-

methoxy-7-(1-methyl-1H-pyrazol-4-yl)-thiazolo [4,5-c]pyridin-

2-yl]-amide

127

1-Methyl-1H-[1,2,3]triazole-4-carboxylic acid [4-methoxy-7-(1-

methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

128

1-Cyano-cyclopropanecarboxylic acid [4-methoxy-7-(1-methyl-1H-

pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

129

3-Cyano-N-[4-methoxy-7-(1-methyl-1H-pyrazol-4-yl)-

thiazolo[4,5-c]pyridin-2-yl]-propionamide

130

2-Methyl-oxazole-5-carboxylic acid [4-methoxy-7-(1-methyl-1H-

pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

131

2-Methyl-thiazole-5-carboxylic acid [4-methoxy-7-(1-methyl-1H-

pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

132

4-Hydroxy-pent-2-ynoic acid [4-methoxy-7-(1-methyl-1H-pyrazol-

4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

133

(S)-3-Methanesulfonyl-pyrrolidine-l-carboxylic acid [4-methoxy-7-

(1-methyl-1H-pyrazol-4-yl)-thiazolo [4,5-c]pyridin-2-yl]-amide

134

(S)-3-Fluoro-pyrrolidine-1-carboxylic acid [4-methoxy-7-(1-methyl-

1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

135

(S)-3-Cyano-pyrrolidine-1-carboxylic acid [4-methoxy-7-(1-methyl-

1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

136

(R)-3-Dimethylaminomethyl-pyrrolidine-l-carboxylic acid [4-

methoxy-7-(1-methyl-1H-pyrazol-4-yl)-thiazolo [4,5-c]pyridin-

2-yl]-amide

137

5-Methyl-isoxazole-4-carboxylic acid (4-methoxy-7-morpholin-4-yl-

thiazolo[4,5-c]pyridin-2-yl)-amide

138

1-(2-Methoxy-ethyl)-1H-[1,2,3]triazole-4-carboxylic acid (4-

methoxy-7-morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

139

1-Methyl-1H-[1,2,3]triazole-4-carboxylic acid (4-methoxy-7-

morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

140

Pyridine-2,5-dicarboxylic acid 2-dimethylamide 5-{[4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo [4,5-c]pyridin-2-yl]-amide}

141

Pyridine-2,5-dicarboxylic acid 2-dimethylamide 5-[(4-methoxy-7-

morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide]

142

1-Methyl-1H-pyrazole-4-carboxylic acid [7-methoxy-4-(tetrahydro-

pyran-4-yl)-1H-benzoimidazol-2-yl]-amide

143

5-Methyl-isoxazole-4-carboxylic acid [4-methoxy-7-(tetrahydro-

pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

144

1-(2-Methoxy-ethyl)-1H-[1,2,3]triazole-4-carboxylic acid [4-

methoxy-7-(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-

amide

145

1-Methyl-1H-[1,2,3]triazole-4-carboxylic acid [4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

146

1-Cyano-cyclopropanecarboxylic acid [4-methoxy-7-(tetrahydro-

pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

147

2-Methyl-oxazole-5-carboxylic acid [4-methoxy-7-(tetrahydro-

pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

148

2-Methyl-thiazole-5-carboxylic acid [4-methoxy-7-(tetrahydro-

pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

149

(S)-3-Methanesulfonyl-pyrrolidine-1-carboxylic acid [4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

150

(S)-3-Fluoro-pyrrolidine-1-carboxylic acid[4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

151

(S)-3-Cyano-pyrrolidine-1-carboxylic acid [4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

152

(R)-3-Dimethylaminomethyl-pyrrolidine-1-carboxylic acid [4-

methoxy-7-(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-

amide

153

1-[4-Methoxy-7-(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-

yl]-3-thiazol-2-ylmethyl-urea

154

1-(2-Methoxy-ethyl)-1H-pyrazole-4-carboxylic acid [4-methoxy-7-

(2-oxa-7-aza-spiro[4.4]non-7-yl)-thiazolo[4,5-c]pyridin-2-

yl]-amide

155

1-Methyl-1H-pyrazole-4-carboxylic acid {4-methoxy-7-[(2-

methoxy-propyl)-methyl-amino]-thiazolo [4,5-c]pyridin-2-

yl}-amide

156

1-Methyl-1H-pyrazole-4-carboxylic acid [4-methoxy-7-(5-oxa-2-

aza-spiro[3.4]oct-2-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

157

1-Methyl-1H-pyrazole-4-carboxylic acid (4-methoxy-7-piperidin-4-

yl-thiazolo[4,5-c]pyridin-2-yl)-amide

158

1-Methyl-1H-pyrazole-4-carboxylic acid (4-methoxy-7-piperidin-3-

yl-thiazolo[4,5-c]pyridin-2-yl)-amide

159

1-Methyl-1H-pyrazole-4-carboxylic acid [7-(carbamoylmethyl-

methyl-amino)-4-methoxy-thiazolo[4,5-c]pyridin-2-yl]-amide

160

1-Methyl-1H-pyrazole-4-carboxylic acid [4-methoxy-7-(2,2,2-

trifluoro-ethoxy)-thiazolo[4,5-c]pyridin-2-yl]-amide

161

4-Hydroxy-4-methyl-piperidine-1-carboxylic acid (4-

fluoromethoxy-7-morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

162

4-Hydroxy-4-methyl-piperidine-1-carboxylic acid (4-

difluoromethoxy-7-morpholin-4-yl-thiazolo[4,5-c]pyridin-2-

yl)-amide

163

N-(4-methoxy-6-methyl-7-morpholino-thiazolo[4,5-c]pyridin-2-yl)-

1-methyl-pyrazole-4-carboxamide

164

N-(6-bromo-4-methoxy-7-morpholino-thiazolo[4,5-c]pyridin-2-yl)-

1-methyl-pyrazole-4-carboxamide

165

1-Methyl-1H-pyrazole-4-carboxylic acid (6-fluoro-4-methoxy-7-

morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

166

N-(6-chloro-4-methoxy-7-morpholino-thiazolo[4,5-c]pyridin-2-yl)-

1-methyl-pyrazole-4-carboxamide

167

Cyclopropanecarboxylic acid (4-methoxy-7-morpholin-4-yl-

thiazolo[4,5-c]pyridin-2-yl)-amide

168

(S)-7-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (4-methoxy-7-

morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

169

(R)-7-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (4-methoxy-7-

morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

170

N-(4-Methoxy-7-morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-4-(2-

oxo-pyrrolidin-l-ylmethyl)-benzamide

171

1-Methyl-1H-pyrazole-4-carboxylic acid (4-methoxy-7-morpholin-

4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

172

(R)-2-Oxa-7-aza-spiro[4.4]nonane-7-carboxylic acid [4-methoxy-7-

(1-methyl-1H-pyrazol-4-yl)-thiazolo [4,5-c]pyridin-2-yl]-amide

173

(S)-2-Oxa-7-aza-Spiro[4.4]nonane-7-carboxylic acid [4-

methoxy-7-(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-

2-yl]-amide

174

3-cyano-N-[4-methoxy-7-(morpholin-4-yl)-[1,3]thiazolo[4,5-

c]pyridin-2-yl]propanamide

175

1-cyano-N-[4-methoxy-7-(morpholin-4-yl)-[1,3]thiazolo[4,5-

c]pyridin-2-yl]cyclopropane-1-carboxamide

176

(S)-7-Oxa-2-aza-Spiro[4.5]decane-2-carboxylic acid [4-methoxy-7-

(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

177

(R)-7-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [4-methoxy-7-

(1-methyl-1H-pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

178

1-Methyl-1H-pyrazole-4-carboxylic acid (6-bromo-4-methoxy-7-

morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

179

Cyclopropanecarboxylic acid [4-methoxy-7-(1-methyl-1H-

pyrazol-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

180

N-[4-Methoxy-7-(tetrahydro-pyran-4-yl)-thiazolo[4,5-

c]pyridin-2-yl]-4-(2-oxo-pyrrolidin-l-ylmethyl)-benzamide

181

2-Methyl-thiazole-5-carboxylic acid [4-methoxy-7-(tetrahydro-

pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

182

2-Oxa-7-aza-spiro[4.4]nonane-7-carboxylic acid [7-(3-ethoxy-

3-methyl-azetidin-1-yl)-4-methoxy-thiazolo[4,5-c]pyridin-

2-yl]-amide

183

2-Oxa-7-aza-spiro[4.4]nonane-7-carboxylic acid (4-methoxy-7-

piperidin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

184

2-Oxa-7-aza-spiro[4.4]nonane-7-carboxylic acid [4-

methoxy-7-(5-oxa-2-aza-Spiro[3.4]oct-2-yl)-

thiazolo[4,5-c]pyridin-2-yl]-amide

185

2-Oxa-7-aza-spiro[4.4]nonane-7-carboxylic acid [4-

methoxy-7-(3-methoxy-3-methyl-azetidin-1-yl)-thiazolo[4,5-

c]pyridin-2-yl]-amide

186

2-Methyl-oxazole-5-carboxylic acid (4-methoxy-7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-amide

187

Cyclopropanecarboxylic acid (4-methoxy-7-phenyl-thiazolo[4,5-

c]pyridin-2-yl)-amide

188

1-Methyl-1H-pyrazole-4-carboxylic acid (4-methoxy-7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-amide

189

N-[4-methoxy-7-(morpholin-4-yl)-[1,3]thiazolo[4,5-

c]pyridin-2-yl]-2-methyl-1,3-oxazole-5-carboxamide

190

2-Methyl-thiazole-5-carboxylic acid (4-methoxy-7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-amide

191

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [4-methoxy-7-(5-

oxa-2-aza-Spiro[3.4]oct-2-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

192

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (4-methoxy-7-

pipendin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

193

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [7-(4-fluoro-

phenyl)-4-methoxy-thiazolo[4,5-c]pyridin-2-yl]-amide

194

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [7-(3-fluoro-

phenyl)-4-methoxy-thiazolo[4,5-c]pyridin-2-yl]-amide

195

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [7-(2-fluoro-

phenyl)-4-methoxy-thiazolo[4,5-c]pyridin-2-yl]-amide

196

1-Dimethylaminomethyl-cyclopropanecarboxylic acid(4-methoxy-

7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

197

Cyclopropane-1,1-dicarboxylic acid dimethylamide (4-methoxy-7-

phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

198

1-Imidazol-1-ylmethyl-cyclopropanecarboxylic acid (4-methoxy-7-

phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

199

1-Methyl-1H-pyrazole-4-carboxylic acid (4-hydroxy-7-morpholin-4-

yl-thiazolo[4,5-c]pyridin-2-yl)-amide

200

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (4-methoxy-7-

piperidin-3-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

201

1-amino-N-{4-methoxy-7-phenyl-[1,3]thiazolo[4,5-c]pyridin-2-

yl}-8-azaspiro[4.5]decane-8-carboxamide

202

(1 S, 2 S)-2-methoxy-N-{4-methoxy-7-phenyl-[1,3]thiazolo[4,5-

c]pyridin-2-yl}cyclopropane-1-carboxamide

203

1-Amino-cyclopropanecarboxylic acid (4-methoxy-7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-amide

204

(S)-7-Oxa-2-aza-Spiro[4.5]decane-2-carboxylic acid (4-methoxy-7-

phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

205

(R)-7-Oxa-2-aza-spiro[4.5]decane-2-carboxylicacid (4-methoxy-7-

phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

206

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (4-methoxy-7-

pyridm-3-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

207

(S)-2-Oxa-7-aza-Spiro[4.4]nonane-7-carboxylic acid(4-methoxy-7-

phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

208

(R)-2-Oxa-7-aza-spiro[4.4]nonane-7-carboxylic acid(4-methoxy-7-

phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

209

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [7-(2,3-difluoro-

phenyl)-4-methoxy-thiazolo[4,5-c]pyridin-2-yl]-amide

210

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [7-(2,5-difluoro-

phenyl)-4-methoxy-thiazolo[4,5-c]pyridin-2-yl]-amide

211

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (4-methoxy-7-

pyridm-2-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

212

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (4-methoxy-7-

pyridm-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

213

4-(2,5-Dioxo-pyrrolidin-1-yl)-N-(4-methoxy-7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-benzamide

214

4-(2,5-Dioxo-pyrrolidin-1-yl)-N-(4-methoxy-7-morpholin-4-yl-

thiazolo[4,5-c]pyridin-2-yl)-benzamide

215

(R)-1-Amino-8-aza-spiro[4.5]decane-8-carboxylic acid (4-methoxy-

7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

216

(S)-1-Amino-8-aza-spiro[4.5]decane-8-carboxylic acid (4-methoxy-

7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

217

1-Methyl-1H-pyrazole-4-carboxylic acid (6-cyano-4-methoxy-7-

morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

218

N-(4-Methoxy-7-pyridin-3-yl-thiazolo[4,5-c]pyridin-2-yl)-N′,N′-

dimethyl-terephthalamide

219

N-(4-Methoxy-7-pyridin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-N′,N′-

dimethyl-terephthalamide

220

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (6-chloro-4-

methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

221

1-Methyl-1H-pyrazole-4-carboxylic acid (6-chloro-4-methoxy-7-

morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

222

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (6-cyano-4-

methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

223

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (4-methoxy-6-

methyl-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

224

N-{4-Methoxy-7-[3-(2-methoxy-ethoxy)-phenyl]-thiazolo[4,5-

c]pyridin-2-yl}-N′,N′-dimethyl-terephthalamide

225

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid {4-methoxy-7-[3-

(2-methoxy-ethoxy)-phenyl]-thiazolo[4,5-c]pyridin-2-yl}-amide

226

4-(2,5-Dioxo-pyrrolidin-1-yl)-N-(6-fluoro-4-methoxy-7-morpholin-

4-yl-thiazolo[4,5-c]pyridin-2-yl)-benzamide

227

N-(2-Hydroxy-ethyl)-N′-(4-methoxy-7-phenyl-thiazolo[4,5-

c]pyridin-2-yl)-N-methyl-terephthalamide

228

N-(2-Hydroxy-ethyl)-N′-(4-methoxy-7-phenyl-thiazolo[4,5-

c]pyridin-2-yl)-terephthalamide

229

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (6-fluoro-4-

methoxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

230

N-(2-Dimethylamino-ethyl)-N′-(4-methoxy-7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-terephthalamide

231

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid (4,6-dimethyl-7-

phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

232

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [4-methoxy-7-

(tetrahydro-pyran-4-yl)-thiazolo[4,5-c]pyridin-2-yl]-amide

233

N-{4-methoxy-7-[3-(2-methoxyethoxy)phenyl]-[1,3]thiazolo[4,5-

c]pyridin-2-yl}-1-(2-methoxyethyl)-1H-pyrazole-4-carboxamide

234

N-{6-fluoro-4-methoxy-7-[3-(2-methoxyethoxy)phenyl]-

[1,3]thiazolo[4,5-c]pyridin-2-yl}-8-oxa-2-azaspiro[4.5]decane-

2-carboxamide

235

N-[4-methoxy-7-(oxan-4-yl)-[1,3]thiazolo[4,5-c]pyridin-2-

yl]-1-methyl-1H-pyrazole-4-carboxamide

236

N-[4-methoxy-7-(2-methoxyphenyl)-[1,3]thiazolo[4,5-

c]pyridin-2-yl]-8-oxa-2-azaspiro[4.5]decane-2-carboxamide

237

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [7-(3,6-dihydro-

2H-pyran-4-yl)-4-methoxy-thiazolo[4,5-c]pyridin-2-yl]-amide

238

N-[7-(3,6-dihydro-2H-pyran-4-yl)-4-methoxy-[1,3]thiazolo[4,5-

c]pyridin-2-yl]-1-methyl-1H-pyrazole-4-carboxamide

239

N-[7-(2,6-dimethoxypyridin-3-yl)-4-methoxy-[1,3]thiazolo[4,5-

c]pyridin-2-yl]-8-oxa-2-azaspiro[4.5]decane-2-carboxamide

240

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylicacid (6-fluoro-4-

hydroxy-7-phenyl-thiazolo[4,5-c]pyridin-2-yl)-amide

241

2-amino-N-[4-methoxy-7-(oxan-4-yl)-[1,3]thiazolo[4,5-

c]pyridin-2-yl]-1,3-thiazole-5-carboxamide

242

3-Amino-pyrrolidine-1-carboxylic acid (4-methoxy-7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-amide

243

(R)-3-Amino-pyrrolidine-1-carboxylic acid (4-methoxy-7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-amide

244

(S)-3-Amino-pyrrolidine-1-carboxylic acid (4-methoxy-7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-amide

245

8-Oxa-2-aza-spiro[4.5]decane-2-carboxylicacid (7-phenyl-

thiazolo[4,5-c]pyridin-2-yl)-amide

246

1-(2-Methoxy-ethyl)-1H-pyrazole-4-carboxylic acid (6-fluoro-4-

methoxy-7-morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

247

Bicyclo[1.1.1]pentane-1,3-dicarboxylic acid dimethylamide (4-

methoxy-7-morpholin-4-yl-thiazolo[4,5-c]pyridin-2-yl)-amide

248

N-(2-Hydroxy-ethyl)-N′-[4-methoxy-7-(tetrahydro-pyran-4-yl)-

thiazolo[4,5-c]pyridin-2-yl]-N-methyl-terephthalamide

or physiologically acceptable salts, solvates, prodrugs or stereoisomers thereof, including mixtures thereof in all ratios.

13. A process for the preparation of a compound of the formula I, according to claim 1 , comprising

a) a compound of the formula II undergoes a reduction to give a compound of formula III, a compound of formula III is reacted with a compound of formula IV at elevated temperature to give a compound of formula V, a compound of formula V is converted to a compound of the formula VI employing the use of catalyst and base, a compound of formula VI is converted to a compound of the formula VII by bromination, a compound of the formula VII is converted to a compound of the formula VIII under essentially basic conditions and a compound of the formula VIII is reacted with a compound of the formula IX under standard amidation or carbamide formation conditions to give a compound of the formula I,

b) a compound of the formula V is reacted with a compound of the formula X under Suzuki-type reaction conditions to give a compound of the formula VI, a compound of formula VI is converted to a compound of the formula VII by bromination, a compound of formula VII is converted to a compound of the formula VIII under essentially basic conditions and a compound of the formula VIII is reacted with a compound of the formula IX under standard amidation or carbamide formation conditions to give a compound of the formula I,

c) a compound of the formula XII is iodinated to give a compound of the formula XIII, a compound of formula XIII is converted to a compound of the formula XIV by treatment with base and an electrophile, a compound of formula XIV is converted to a compound of the formula XV by reduction, a compound of formula XV is reacted with a compound of formula IV at elevated temperature to give a compound of the formula XVI, a compound of formula XVI is converted under catalytic conditions to a compound of the formula XVII, a compound of the formula XVII is converted to a compound of the formula VIII under basic conditions and a compound of the formula VIII is reacted with a compound of the formula IX under standard amidation or carbamide formation conditions to give a compound of the formula I,

d) the base of a compound of the formula I is converted into one of its salts by treatment with an acid, or

e) an acid of a compound of the formula I is converted into one of its salts by treatment with a base.

14. The compound according to claim 1 or physiologically acceptable salts, solvates, prodrugs or stereoisomers thereof, including mixtures thereof in all ratios, as adenosine A 2A and/or A 2B receptor inhibitor.

15. A pharmaceutical composition comprising at least one compound according to claim 1 and/or physiologically acceptable salts, solvates, prodrugs or stereoisomers thereof, including mixtures thereof in all ratios, and a pharmaceutically acceptable carrier.

16. The pharmaceutical composition according to claim 15 , comprising further excipients and/or adjuvants.

17. A process for the preparation of a pharmaceutical preparation, wherein a compound according to claim 1 and/or one of its physiologically acceptable salts, solvates, prodrugs or stereoisomers, including mixtures thereof in all ratios, is brought into a suitable dosage form together with a solid, liquid or semi-liquid excipient or adjuvant.

18. A method of treating a cancer that is acute and chronic lymphocytic leukemia, acute granulocytic leukemia, adrenal cortex cancer, bladder cancer, brain cancer, breast cancer, cervical cancer, cervical hyperplasia, cervical cancer, chorio cancer, chronic granulocytic leukemia, chronic lymphocytic leukemia, colon cancer, endometrial cancer, esophageal cancer, essential thrombocytosis, genitourinary carcinoma, glioma, glioblastoma, hairy cell leukemia, head and neck carcinoma, Hodgkin's disease, Kaposi's sarcoma, lung carcinoma, lymphoma, malignant carcinoid carcinoma, malignant hypercalcemia, malignant melanoma, malignant pancreatic insulinoma, medullary thyroid carcinoma, melanoma, multiple myeloma, mycosis fungoides, myeloid and lymphocytic leukemia, neuroblastoma, non-Hodgkin's lymphoma, non-small cell lung cancer, osteogenic sarcoma, ovarian carcinoma, pancreatic carcinoma, polycythemia vera, primary brain carcinoma, primary macroglobulinemia, prostatic cancer, renal cell cancer, rhabdomyosarcoma, skin cancer, small-cell lung cancer, soft-tissue sarcoma, squamous cell cancer, stomach cancer, testicular cancer, thyroid cancer Wilms' tumor in a host in need thereof, comprising administering to said host an effective amount of a compound of claim 1 and/or one of its physiologically acceptable salts, derivatives, solvates, prodrugs and/or stereoisomers, including mixtures thereof in all ratios.

19. A method of treating an infectious disease or disorder in a host in need thereof, comprising administering to said host an effective amount of a compound according to claim 1 and/or one of its physiologically acceptable salts, derivatives, solvates, prodrugs and/or stereoisomers, including mixtures thereof in all ratios, wherein the hyperproliferative disease or disorder is age-related macular degeneration, Crohn's disease, cirrhosis, chronic inflammatory-related disorders, proliferative diabetic retinopathy, proliferative vitreoretinopathy, retinopathy of prematurity, granulomatosis, immune hyperproliferation associated with organ or tissue transplantation or an immunoproliferative disease or disorder that is inflammatory bowel disease, psoriasis, rheumatoid arthritis, systemic lupus erythematosus (SLE), vascular hyperproliferation secondary to retinal hypoxia or vasculitis.

20. The method according to claim 19 , wherein the infectious disease or disorder is

a) virally induced infectious diseases which are caused by retroviruses, hepadnaviruses, herpesviruses, flaviviridae and/or adenoviruses wherein the retroviruses are lentiviruses or oncoretroviruses, wherein the lentivirus is HIV-1, HIV-2, FIV, BIV, SIVs, SHIV, CAEV, VMV or EIAV and the oncoretrovirus is HTLV-I, HTLV-II or BLV, the hepadnavirus is HBV, GSHV or WHV, the herpesivirus is HSV I, HSV II, EBV, VZV, HCMV or HHV 8 and the flaviviridae is HCV, West nile or Yellow Fever,

b) bacterial infectious diseases which are caused by Gram-positive bacteria wherein the Gram-positive bacteria methicillin-susceptible or methicillin-resistant staphylococci, glycopeptides-intermediate susceptible Staphylococcus aureus (GISA), penicillin-susceptible and penicillin-resistant streptococci, enterococci, Clostridium difficile, Listeria monocytogenes, Corynebacterium jeikeium, Chlamydia spp or Mycobacterium tuberculosis,

c) bacterial infectious diseases which are caused by Gram-negative bacteria wherein the Gram-negative bacteria are of the Genus Enterobacteriacae, Klebsiella spp., Enterobacter spp., Citrobacter spp., Serratia spp., Proteus spp., Providencia spp., Salmonella spp., Shigella spp., the genus Pseudomonas, Moraxella spp., Haemophilus spp. or Neisseria spp.,

d) infectious diseases induced by intracellular active parasites that are phylum Apicomplexa, or Sarcomastigophora Cryptosporidia, Sacrocystida, Amoebia, Coccidia and Trichomonadia.

21. Set (kit) consisting of separate packs of

a) an effective amount of a compound according to claim 1 and/or physiologically acceptable salts, derivatives, solvates, prodrugs and stereoisomers thereof, including mixtures thereof in all ratios, and

b) an effective amount of a further medicament active compound.

22. The method according to claim 20 , wherein the methicillin-susceptible and/or methicillin-resistant staphylococci are Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus saprophyticus , or coagulase-negative staphylococci, the penicillin-susceptible and penicillin-resistant streptococci are Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus avium, Streptococcus bovis, Streptococcus lactic, Streptococcus sanguis or Streptococci Group C (GCS), Streptococci Group G (GGS) or viridans streptococci, the enterococci are vancomycinsusceptible or vancomycin-resistant Enterococcus faecalis or Enterococcus faecium , the Chlamydia spp is C. pneumoniae , the Enterobacteriacae are Escherichia , the Pseudomonas are P. aeruginosa , and the Moraxella spp. are M. catarrhalis.

23. The method according to claim 20 , wherein the Sarcomastigophora is Trypanosoma, Plasmodia, Leishmania, Babesia or Theileria.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2025
From: MERCK PATENT GMBH; MERCK HEALTHCARE KGAA
To: DOMAIN THERAPEUTICS
Reel/Frame 072033/0504 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2020
From: TANZER, EVA-MARIA; KLEIN, MARKUS; SCHIEMANN, KAI
To: MERCK PATENT GMBH
Reel/Frame 051976/0667 →
Priority Claims (1)
EP 17184272 · Aug 1, 2017 · regional
Continuity (1)
Related Publication 20200181171A1 · Jun 11, 2020
Cited By (1)
US 12,344,623